ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,065Medicare Part D Prescriptions Filled, Including Refills

Rank: 23 out of 559

$494K Total Retail Price of All Prescriptions

Rank: 33 out of 559

702 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 702 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 702 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 7,377 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LISINOPRIL 703 610 1 1
LEVOTHYROXINE SODIUM 584 411 2 2
SIMVASTATIN 569 419 3 3
HYDROCODONE-ACETAMINOPHEN 389 230 S3 4 7
OMEPRAZOLE 359 198 5 4
METFORMIN HCL 353 240 6 5
AMLODIPINE BESYLATE 310 242 7 6
ALENDRONATE SODIUM 250 194 8 13
GABAPENTIN 228 119 9 9
TRAZODONE HCL 214 126 10 28
SERTRALINE HCL 193 131 11 19
HYDROCHLOROTHIAZIDE 175 139 12 8
FLUTICASONE PROPIONATE 167 98 13 22
METOPROLOL SUCCINATE 164 130 14 16
ATENOLOL 159 119 15 15
LOSARTAN POTASSIUM 156 105 16 14
GLIPIZIDE ER 146 116 17 77
FUROSEMIDE 143 119 18 11
LOVASTATIN 130 115 19 10
POTASSIUM CHLORIDE 127 115 20 23
DOXAZOSIN MESYLATE 124 92 21 43
FLUOXETINE HCL 124 53 21 37
LISINOPRIL-HYDROCHLOROTHIAZIDE 113 83 23 18
FLOVENT HFA 113 55 23 129
CITALOPRAM HBR 106 53 25 21
METOPROLOL TARTRATE 97 62 26 12
TRIAMTERENE-HCTZ 92 75 27 47
MIRTAZAPINE 90 70 28 61
GLIPIZIDE 87 51 29 31
DICLOFENAC SODIUM 82 43 30 81
PRAVASTATIN SODIUM 80 67 31 35
TAMSULOSIN HCL 80 57 31 25
ALLOPURINOL 77 53 33 34
NEXIUM 74 53 34 57
LANTUS 72 41 35 40
RANITIDINE HCL 72 27 35 26
OXYCODONE HCL 69 30 S2 37 32
DONEPEZIL HCL 67 58 38 36
NAMENDA 66 54 39 56
DILTIAZEM ER 64 60 40 118
PAROXETINE HCL 61 40 41 48
ZOLPIDEM TARTRATE 61 37 41 17
FINASTERIDE 61 55 41 59
CLONIDINE HCL 60 42 44 68
MELOXICAM 58 35 45 42
ATORVASTATIN CALCIUM 57 45 46 20
PANTOPRAZOLE SODIUM 57 53 46 41
GLYBURIDE 56 51 R 48 45
TRAMADOL HCL 54 20 49 27
OXYBUTYNIN CHLORIDE 54 0 49 62
BUSPIRONE HCL 53 26 51 172
WARFARIN SODIUM 52 49 52 24
DIGOXIN 51 51 53 94
BUPROPION HCL SR 51 23 53 114
GENERLAC 51 28 53 163
PROAIR HFA 50 25 56 29
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.